{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-253897","form_type":"8-K","ticker":"XMTR","cik":"0001657573","company_name":"Xometry, Inc.","filed_at":"2026-06-02T21:26:17+00:00","discovered_at":"2026-06-02T21:28:00.328258+00:00","generated_at":"2026-06-02T21:29:05.364489+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Xometry announces public offering of 2.65M shares at $85.00; expected net proceeds $215.2M","bullets":["Offering of 2,647,059 shares of Class A common stock at $85.00/share.","Estimated net proceeds of approximately $215.2 million after discounts and expenses.","Underwriters granted 30-day option to purchase up to 397,058 additional shares.","Closing expected on June 3, 2026, subject to customary conditions.","Offering made under shelf registration statement filed June 1, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253897","json":"https://secwatch.observer/filing/0001193125-26-253897.json","markdown":"https://secwatch.observer/filing/0001193125-26-253897.md","text":"https://secwatch.observer/filing/0001193125-26-253897.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1657573/000119312526253897/0001193125-26-253897-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1657573/000119312526253897/d109952d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T21:29:05.364489+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001628280-26-039818","ticker":"ARVN","company_name":"ARVINAS, INC.","filed_at":"2026-06-02T20:39:40+00:00","headline":"Arvinas to out-license ARV-806 after completing Phase 1 dose escalation","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039818","json":"https://secwatch.observer/filing/0001628280-26-039818.json","markdown":"https://secwatch.observer/filing/0001628280-26-039818.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026039818/0001628280-26-039818-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026039818/arvn-20260602.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-253580","ticker":"TTI","company_name":"TETRA TECHNOLOGIES INC","filed_at":"2026-06-02T20:26:51+00:00","headline":"TETRA announces $100M common stock offering, Arkansas Bromine Project approved with $220M remaining capex","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253580","json":"https://secwatch.observer/filing/0001193125-26-253580.json","markdown":"https://secwatch.observer/filing/0001193125-26-253580.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/844965/000119312526253580/0001193125-26-253580-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/844965/000119312526253580/d39009d8k.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-069482","ticker":"CEG","company_name":"Constellation Energy Corp","filed_at":"2026-06-02T20:15:28+00:00","headline":"Constellation Energy secondary offering of 11M shares with concurrent $558M share repurchase","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069482","json":"https://secwatch.observer/filing/0001104659-26-069482.json","markdown":"https://secwatch.observer/filing/0001104659-26-069482.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1868275/000110465926069482/0001104659-26-069482-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1868275/000110465926069482/tm2616531d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001999371-26-011900","ticker":null,"company_name":"CNL Strategic Capital, LLC","filed_at":"2026-06-02T20:04:39+00:00","headline":"Shareholders reject enhanced liquidity plan (25% repurchase); loan amended for equity buybacks","event_type":"other_material","sec_items":["1.01","2.03","5.07","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001999371-26-011900","json":"https://secwatch.observer/filing/0001999371-26-011900.json","markdown":"https://secwatch.observer/filing/0001999371-26-011900.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684682/000199937126011900/0001999371-26-011900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684682/000199937126011900/cnl-8k_052726.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-064144","ticker":"INMB","company_name":"Inmune Bio, Inc.","filed_at":"2026-06-02T20:00:20+00:00","headline":"INmune Bio reports statistically significant white matter MRI biomarker in Phase 2 Alzheimer's trial","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-064144","json":"https://secwatch.observer/filing/0001213900-26-064144.json","markdown":"https://secwatch.observer/filing/0001213900-26-064144.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026064144/0001213900-26-064144-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026064144/ea0293325-8k_inmune.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026769","ticker":"MBOT","company_name":"Microbot Medical Inc.","filed_at":"2026-06-02T12:30:26+00:00","headline":"Microbot Medical secures first North Carolina customer for LIBERTY robotic system","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026769","json":"https://secwatch.observer/filing/0001493152-26-026769.json","markdown":"https://secwatch.observer/filing/0001493152-26-026769.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315226026769/0001493152-26-026769-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315226026769/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-252530","ticker":"SAIA","company_name":"SAIA INC","filed_at":"2026-06-02T11:45:16+00:00","headline":"Saia reports April/May LTL shipments up 5.6%/3.7%, tonnage up 6.9%/8.4% YoY","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-252530","json":"https://secwatch.observer/filing/0001193125-26-252530.json","markdown":"https://secwatch.observer/filing/0001193125-26-252530.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177702/000119312526252530/0001193125-26-252530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177702/000119312526252530/saia-20260602.htm"},"side_by_side_evidence":null},{"accession":"0001674930-26-000028","ticker":"FLGT","company_name":"Fulgent Genetics, Inc.","filed_at":"2026-06-01T23:07:35+00:00","headline":"Fulgent Genetics reports encouraging Phase 2 data for FID-007 in HNSCC at ASCO 2026","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001674930-26-000028","json":"https://secwatch.observer/filing/0001674930-26-000028.json","markdown":"https://secwatch.observer/filing/0001674930-26-000028.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000167493026000028/0001674930-26-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000167493026000028/flgt-20260601.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}